Fluorescence-Guided Surgery for Hepatoblastoma with Indocyanine Green

Fluorescence-guided surgery with indocyanine green (ICG) for malignant hepatic tumors has been gaining more attention with technical advancements. Since hepatoblastomas (HBs) possess similar features to hepatocellular carcinoma, fluorescence-guided surgery can be used for HBs, as aggressive surgical...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Yohei, Ohno, Michinobu, Fujino, Akihiro, Kanamori, Yutaka, Irie, Rie, Yoshioka, Takako, Miyazaki, Osamu, Uchida, Hajime, Fukuda, Akinari, Sakamoto, Seisuke, Kasahara, Mureo, Matsumoto, Kimikazu, Fuchimoto, Yasushi, Hoshino, Ken, Kuroda, Tatsuo, Hishiki, Tomoro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721588/
https://www.ncbi.nlm.nih.gov/pubmed/31434361
http://dx.doi.org/10.3390/cancers11081215
Descripción
Sumario:Fluorescence-guided surgery with indocyanine green (ICG) for malignant hepatic tumors has been gaining more attention with technical advancements. Since hepatoblastomas (HBs) possess similar features to hepatocellular carcinoma, fluorescence-guided surgery can be used for HBs, as aggressive surgical resection, even for distant metastases of HBs, often contributes positively to R0 (complete) resection and subsequent patient survival. Despite a few caveats, fluorescence-guided surgery allows for the more sensitive identification of lesions that may go undetected by conventional imaging or be invisible macroscopically. This leads to precise resection of distant metastatic tumors as well as primary liver tumors.

Ejemplares similares